ten23 health AG
ten23 health AG, headquartered in Switzerland (CH), is a pioneering company in the biopharmaceutical industry, specialising in the development of innovative drug delivery systems. Founded in 2020, ten23 health has quickly established itself as a leader in the field, focusing on the creation of unique formulations that enhance the efficacy and safety of therapeutic agents. With a strong operational presence across Europe, ten23 health AG offers a range of core services, including formulation development, analytical services, and regulatory support. Their commitment to advancing drug delivery technologies sets them apart, enabling clients to navigate complex challenges in the pharmaceutical landscape. Recognised for their expertise and innovative solutions, ten23 health continues to make significant strides in improving patient outcomes and solidifying their market position.
DitchCarbon Score
How does ten23 health AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ten23 health AG's score of 47 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ten23 health AG's reported carbon emissions
In 2024, ten23 health AG reported total carbon emissions of approximately 13,044,500 kg CO2e, with significant contributions from Scope 3 emissions, particularly in capital goods (10,710,000 kg CO2e) and purchased goods and services (1,791,000 kg CO2e). Scope 1 emissions were recorded at 700 kg CO2e, while Scope 2 emissions totalled approximately 86,300 kg CO2e (market-based). Comparatively, in 2023, the company emitted about 15,423,300 kg CO2e, indicating a reduction in total emissions year-on-year. The breakdown for 2023 included 500 kg CO2e for Scope 1, 112,700 kg CO2e for Scope 2 (market-based), and 15,423,300 kg CO2e for Scope 3. In 2022, emissions were approximately 5,771,800 kg CO2e, with Scope 1 at 400 kg CO2e and Scope 2 at 131,300 kg CO2e (market-based). Ten23 health AG has set ambitious climate commitments, aiming to reduce total emissions (Scope 1, 2, and 3) by 90% by 2050 from a 2023 baseline. Additionally, the company targets a 42% reduction in Scope 1 and Scope 2 emissions by 2030, also from a 2023 base year. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect the company's commitment to achieving net-zero emissions by 2050. The company’s emissions data is not cascaded from any parent organization, indicating that these figures are independently reported.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | - | 000 | 000 | 000 |
| Scope 2 | 115,600 | 000,000 | 000,000 | 00,000 |
| Scope 3 | 282,900 | 0,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ten23 health AG is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
